ADMA Biologics Issues Press Release Under Regulation FD

What Happened

• On March 27, 2026, ADMA Biologics, Inc. (ADMA) filed a Form 8-K reporting a Regulation FD disclosure: the company issued a press release that is furnished as Exhibit 99.1 and incorporated by reference in the filing.

Key Details

• Filing date: March 27, 2026 (Form 8-K, Item 7.01).
• Disclosure type: Regulation FD press release furnished as Exhibit 99.1.
• The filing also includes an interactive XBRL cover page (Exhibit 104).

Why It Matters

• This 8-K notifies investors that ADMA publicly released information via a press release on March 27, 2026. Investors should read the attached Exhibit 99.1 press release to see the specific news or updates the company disclosed.